Farrerol ameliorates diabetic cardiomyopathy by inhibiting ferroptosis <i>via</i> miR-29b-3p/SIRT1 signaling pathway in endothelial cells
Therefore, FA has a potential therapeutic effect on cardiac microvascular dysfunction by suppressing EC ferroptosis through the miR-29b-3p/SIRT1 axis.
Authors
- Zhengang Yang (ORCID: https://orcid.org/0000-0003-2447-6540)
- Liuping Zhang (ORCID: https://orcid.org/0000-0001-9531-7681)
- Xiaobing Yu (ORCID: https://orcid.org/0000-0002-3318-1720)
- Jufang Chi (ORCID: https://orcid.org/0000-0003-1691-7369)
- Yan Guo (ORCID: https://orcid.org/0000-0003-3688-9529)
- Haotian Gu (ORCID: https://orcid.org/0000-0003-3270-4347)
- Yujie Wang
- Hui Lin
Institutions
- Wenzhou Medical University (CN)
- Ningbo Medical Center Lihuili Hospital (CN)
- Hangzhou Hospital of Traditional Chinese Medicine (CN)
- Ningbo University Affiliated Hospital (CN)
- Shaoxing People's Hospital (CN)
Publication Details
- Journal
- World Journal of Diabetes
- Published
- 2025-09-10
- DOI
- https://doi.org/10.4239/wjd.v16.i9.109553
- Citations
- 3
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 4.56